Clinical Trial Update: Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update examines the efficacy of an epidermal growth factor receptor tyrosine kinase inhibitor used with early stereotactic body radi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EGFR tyrosine kinase inhibitor (unspecified)

Snippet

Sponsor: Haihua Yang | Conditions: Advanced Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN